Chester County News and Community Website
PHILADELPHIA, PA — Latus Bio Inc. has reported preclinical advances in delivering gene therapies to brain and kidney cells, demonstrating improved targeting compared with conventional viral delivery technology as the …
Latus Bio Reports Gene Delivery Gains in Brain, Kidney Studies Read More
RADNOR, PA — Mineralys Therapeutics Inc. (Nasdaq: MLYS) reported that its experimental hypertension drug lorundrostat significantly reduced blood pressure and urinary protein levels in patients with chronic kidney disease, according …
Mineralys Drug Lowers Blood Pressure in Kidney Disease Trial Read More
WAYNE, PA — Aclaris Therapeutics Inc. (Nasdaq: ACRS) plans to advance its experimental antibody ATI-052 into a Phase 2b trial for eosinophilic esophagitis in early 2027, concentrating development spending on …
Aclaris Prioritizes Esophageal Drug Trial After Early Results Read More
WILMINGTON, DE — AstraZeneca and Amgen reported that their immunotherapy TEZSPIRE significantly reduced esophageal inflammation and swallowing difficulties in a Phase III clinical trial, strengthening the companies’ case for expanding …
AstraZeneca, Amgen Report Phase III Success for TEZSPIRE Read More
SPRING HOUSE, PA — Johnson & Johnson (NYSE: JNJ) reported that its Crohn’s disease treatment Tremfya sustained or improved fistula remission through 48 weeks in a Phase 3 clinical trial, …
J&J’s Tremfya Sustains Crohn’s Remission Through 48 Weeks Read More
MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) will present updates on its experimental Alzheimer’s disease treatment buntanetap at a November medical conference in Boston as the Malvern-based biotechnology company …
Annovis Targets 2027 Alzheimer’s Drug Data Readout Read More
NEWTOWN SQUARE, PA — ArriVent BioPharma Inc. (Nasdaq: AVBP) reported a 68% tumor response rate and median progression-free survival of 16 months at the higher dose of its experimental lung …
ArriVent Lung Cancer Drug Shows 68% Response Rate in Trial Read More
WAYNE, PA — Teleflex Incorporated (NYSE: TFX) has completed enrollment of 102 patients in a European clinical study evaluating longer versions of its dissolvable magnesium coronary scaffold, advancing research into …
Teleflex Completes Enrollment in Coronary Scaffold Trial Read More
WILMINGTON, DE — Prelude Therapeutics Inc. (Nasdaq: PRLD) has entered a clinical trial collaboration with Eli Lilly and Co. to evaluate an experimental breast cancer treatment alongside two Lilly drugs, …
Prelude Partners With Lilly to Test Breast Cancer Drug Combinations Read More NEWTOWN SQUARE, PA — ArriVent BioPharma Inc. (Nasdaq: AVBP) has dosed the first patient in a U.S. Phase 1 clinical trial of ARR-002, an experimental antibody-drug conjugate targeting ovarian and …
ArriVent Advances Cancer Drug Pipeline With First U.S. Trial Read More